About Paolo Tombesi
Paolo Tombesi is an executive officer at Avenzo Therapeutics.
Paolo Tombesi reports to the SEC as an officer of 3 public companies: Turning Point Therapeutics (TPTX), Epizyme (EPZM) and Insmed (INSM).
Paolo Tombesi first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Paolo Tombesi in the role, so the role may have started earlier or lasted longer.
TI
Turning Point Therapeutics, Inc.
EVP & Chief Financial Officer
2021 – 2022 · Public company (TPTX)
EI
Epizyme, Inc.
Chief Financial Officer
2019 – 2021 · Public company (EPZM)
II
Insmed Inc.
Chief Financial Officer
2017 – 2019 · Public company (INSM)
Key Colleagues at Startups
The people Paolo Tombesi works with at each company, as listed on that company's latest Form D.
Avenzo Therapeutics, Inc. · Form D, Sep 5, 2025
CG
Carl Gordon
Director
GN
Garry Nicholson
Director
PM
Patrick Machado
Director
JL
Judith Li
Director
MH
Mohammad Hirmand
Executive officer
SG
Simeon George
Director
SL
Scott Lipman
Executive officer
AC
Athena Countouriotis
Executive officer and director
BS
Brian Sun
Executive officer
JA
Jakob Dupont, M.D., M.A.
Director